Literature DB >> 15142488

Controlling Neuropathic Pain in HIV.

Susama Verma1, Lydia Estanislao, Letty Mintz, David Simpson.   

Abstract

Neuropathic pain is associated with numerous systemic illnesses, including HIV infection. The diagnosis and management of peripheral neuropathy presents diagnostic and therapeutic challenges. Among various forms of HIV-associated peripheral neuropathies, distal symmetrical polyneuropathy (DSP) is the most common. DSP may be caused or exacerbated by neurotoxic antiretrovirals, particularly the dideoxynucleoside analogues (d-drugs). Selection of appropriate pharmacologic intervention for peripheral neuropathy should be based on efficacy, safety, ease of administration, and cost. We review treatment options for painful HIV neuropathy, including experimental agents studied in recent and ongoing clinical trials.

Entities:  

Year:  2004        PMID: 15142488     DOI: 10.1007/s11908-004-0014-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  31 in total

1.  Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group.

Authors:  D M Simpson; D Dorfman; R K Olney; G McKinley; J Dobkin; Y So; J Berger; M B Ferdon; B Friedman
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

Review 2.  Cytomegalovirus polyradiculopathy in patients with AIDS.

Authors:  H J Anders; F D Goebel
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

3.  Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization.

Authors:  T H Brannagan; G J Nuovo; A P Hays; N Latov
Journal:  Ann Neurol       Date:  1997-09       Impact factor: 10.422

4.  Topical capsaicin in the management of HIV-associated peripheral neuropathy.

Authors:  J A Paice; C E Ferrans; F R Lashley; S Shott; V Vizgirda; D Pitrak
Journal:  J Pain Symptom Manage       Date:  2000-01       Impact factor: 3.612

5.  Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels.

Authors:  David M Simpson; Anna-Bettina Haidich; Giovanni Schifitto; Constantin T Yiannoutsos; Anthony P Geraci; Justin C McArthur; David A Katzenstein
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

6.  Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

Authors:  J C Shlay; K Chaloner; M B Max; B Flaws; P Reichelderfer; D Wentworth; S Hillman; B Brizz; D L Cohn
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

7.  Progression of distal-symmetric polyneuropathy in HIV infection: a prospective study.

Authors:  I W Husstedt; K H Grotemeyer; H Busch; W Zidek
Journal:  AIDS       Date:  1993-08       Impact factor: 4.177

8.  Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial.

Authors:  C A Kemper; G Kent; S Burton; S C Deresinski
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-12-01

9.  A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.

Authors:  K Kieburtz; D Simpson; C Yiannoutsos; M B Max; C D Hall; R J Ellis; C M Marra; R McKendall; E Singer; G J Dal Pan; D B Clifford; T Tucker; B Cohen
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

10.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Authors:  D D Ho; T R Rota; R T Schooley; J C Kaplan; J D Allan; J E Groopman; L Resnick; D Felsenstein; C A Andrews; M S Hirsch
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

View more
  8 in total

1.  Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

Authors:  Ronald J Ellis; Debralee Rosario; David B Clifford; Justin C McArthur; David Simpson; Terry Alexander; Benjamin B Gelman; Florin Vaida; Ann Collier; Christina M Marra; Beau Ances; J Hampton Atkinson; Robert H Dworkin; Susan Morgello; Igor Grant
Journal:  Arch Neurol       Date:  2010-05

Review 2.  HIV-associated neuropathic pain: epidemiology, pathophysiology and management.

Authors:  Susama Verma; Lydia Estanislao; David Simpson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  HIV Distal Neuropathic Pain Is Associated with Smaller Ventral Posterior Cingulate Cortex.

Authors:  John R Keltner; Colm G Connolly; Florin Vaida; Mark Jenkinson; Christine Fennema-Notestine; Sarah Archibald; Cherine Akkari; Alexandra Schlein; Jisu Lee; Dongzhe Wang; Sung Kim; Han Li; Austin Rennels; David J Miller; George Kesidis; Donald R Franklin; Chelsea Sanders; Stephanie Corkran; Igor Grant; Gregory G Brown; J Hampton Atkinson; Ronald J Ellis
Journal:  Pain Med       Date:  2017-03-01       Impact factor: 3.750

Review 4.  Treatment of painful polyneuropathies.

Authors:  Bruce Nicholson
Journal:  Curr Pain Headache Rep       Date:  2005-06

5.  Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.

Authors:  D M Simpson; G Schifitto; D B Clifford; T K Murphy; E Durso-De Cruz; P Glue; E Whalen; B Emir; G N Scott; R Freeman
Journal:  Neurology       Date:  2010-02-02       Impact factor: 9.910

6.  HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter.

Authors:  John R Keltner; Christine Fennema-Notestine; Florin Vaida; Dongzhe Wang; Donald R Franklin; Robert H Dworkin; Chelsea Sanders; J Allen McCutchan; Sarah L Archibald; David J Miller; George Kesidis; Clint Cushman; Sung Min Kim; Ian Abramson; Michael J Taylor; Rebecca J Theilmann; Michelle D Julaton; Randy J Notestine; Stephanie Corkran; Mariana Cherner; Nichole A Duarte; Terry Alexander; Jessica Robinson-Papp; Benjamin B Gelman; David M Simpson; Ann C Collier; Christina M Marra; Susan Morgello; Greg Brown; Igor Grant; J Hampton Atkinson; Terry L Jernigan; Ronald J Ellis
Journal:  J Neurovirol       Date:  2014-02-19       Impact factor: 2.643

7.  Health-related quality of life 'well-being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity.

Authors:  John R Keltner; Florin Vaida; Ronald J Ellis; Tobias Moeller-Bertram; Chelsea Fitzsimmons; Nichole A Duarte; Jessica Robinson-Papp; Robert H Dworkin; David B Clifford; Justin C McArthur; David M Simpson; Ann C Collier; Christina M Marra; J Hampton Atkinson; Igor Grant
Journal:  Psychosomatics       Date:  2012 Jul-Aug       Impact factor: 2.386

8.  Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.

Authors:  Neha Munawar; Mabayoje A Oriowo; Willias Masocha
Journal:  Front Pharmacol       Date:  2017-03-20       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.